Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein beta-8 (HSPB8) is a small heat shock protein functioning primarily as a molecular chaperone that helps maintain protein homeostasis, particularly under cellular stress. It prevents irreversible protein aggregation, promotes the degradation of misfolded proteins (with BAG3 via autophagy), and is expressed throughout the body, especially in muscle and nerve tissues. Mutations in the HSPB8 gene are associated with hereditary neuromuscular diseases, notably distal hereditary motor neuropathy type II and Charcot-Marie-Tooth disease type 2L. HSPB8 activity is central to cytoskeletal maintenance, muscle contraction, and protecting cells from apoptotic signals. Aberrant HSPB8 function or expression can lead to neuronal vulnerability, impaired muscle function, and may contribute to tumorigenesis in certain settings
Chaperone modulation (prevents aggregate formation, promotes degradation of misfolded proteins via autophagy)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein beta-8 (HSPB8).